(QSIG) WisdomTree U.S. High Yield - Ratings and Ratios

Exchange: BATS • Country: USA • Currency: USD • Type: Etf • ISIN: (N/A)

QSIG: Corporate Bonds, Bond Fund, ETF, U.S., Short-Term

The WisdomTree U.S. High Yield Corporate Bond Fund (BATS:QSIG) is an ETF that focuses on capturing the performance of a specific segment of the U.S. corporate bond market, targeting issuers with favorable fundamental and income characteristics. The fund is designed to invest at least 80% of its total assets in securities that are part of its underlying index or have similar economic characteristics, making it a relatively focused investment vehicle.

Given its non-diversified nature, QSIG is more susceptible to issuer-specific risks, meaning that the performance of a few key holdings can significantly impact the overall fund performance. However, this also allows the fund to capitalize on the potential upside of its targeted investments. The ETFs underlying index is designed to tap into the short-term U.S. investment-grade corporate bond market, which can provide a relatively stable income stream.

Analyzing the , we observe that QSIGs last price is $48.50, slightly above its SMA20 and SMA50, indicating a positive short-term trend. The SMA200 at $47.60 suggests that the fund has been on an upward trajectory over the longer term. The ATR of 0.12, or 0.25%, indicates relatively low volatility. Considering these technical indicators, along with the showing an AUM of $48.40M USD, we can infer that the fund has a stable asset base.

Forecasting future performance based on the available and , it is plausible that QSIG will continue its upward trend, potentially reaching or slightly exceeding its 52-week high of $48.58, driven by its favorable positioning within the short-term corporate bond market. However, the non-diversified nature of the fund and the inherent risks associated with corporate bond investments, such as credit risk, necessitate a cautious approach. Investors should closely monitor the funds performance and adjust their strategies accordingly to mitigate potential downsides.

Additional Sources for QSIG ETF

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle

QSIG ETF Overview

Market Cap in USD 49m
Category Short-Term Bond
TER 0.38%
IPO / Inception 2016-04-27

QSIG ETF Ratings

Growth Rating 39.6
Fundamental -
Dividend Rating 73.1
Rel. Strength 8.87
Analysts -
Fair Price Momentum 47.65 USD
Fair Price DCF -

QSIG Dividends

Dividend Yield 12m 4.11%
Yield on Cost 5y 4.43%
Annual Growth 5y 12.02%
Payout Consistency 95.9%
Payout Ratio %

QSIG Growth Ratios

Growth Correlation 3m 81.8%
Growth Correlation 12m 92.2%
Growth Correlation 5y 28.7%
CAGR 5y 1.73%
CAGR/Max DD 5y 0.18
Sharpe Ratio 12m 1.27
Alpha 2.68
Beta -0.003
Volatility 2.39%
Current Volume 0.2k
Average Volume 20d 1.2k
What is the price of QSIG shares?
As of June 02, 2025, the stock is trading at USD 48.48 with a total of 211 shares traded.
Over the past week, the price has changed by +0.17%, over one month by +0.43%, over three months by +1.17% and over the past year by +6.48%.
Is WisdomTree U.S. High Yield a good stock to buy?
Partly, yes. Based on ValueRay´s Analyses, WisdomTree U.S. High Yield (BATS:QSIG) is currently (June 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 39.62 and therefor an somewhat technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of QSIG is around 47.65 USD . This means that QSIG is currently overvalued and has a potential downside of -1.71%.
Is QSIG a buy, sell or hold?
WisdomTree U.S. High Yield has no consensus analysts rating.
What are the forecasts for QSIG share price target?
According to our own proprietary Forecast Model, QSIG WisdomTree U.S. High Yield will be worth about 51.5 in June 2026. The stock is currently trading at 48.48. This means that the stock has a potential upside of +6.15%.
Issuer Target Up/Down from current
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 51.5 6.1%